BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21094517)

  • 1. Disease-modifying effect and economic implications of sublingual immunotherapy.
    Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2011 Jan; 127(1):44-5. PubMed ID: 21094517
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose sublingual immunotherapy: too much of the good?
    Reider N
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):125. PubMed ID: 16937740
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublingual immunotherapy: no more doubts.
    Passalacqua G; Lombardi C; Guerra L; Compalati E; Fumagalli F; Canonica GW
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):314-20. PubMed ID: 17066650
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms.
    Bousquet J
    Allergy; 2005 Jan; 60(1):1-3. PubMed ID: 15575923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Desensitization -- at home and without pricks. How effective is sublingual immunotherapy? Interview by Erik Heintz].
    Darsow U
    MMW Fortschr Med; 2005 Aug; 147(33-34):15. PubMed ID: 16144088
    [No Abstract]   [Full Text] [Related]  

  • 6. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic aspects of sublingual immunotherapy.
    Incorvaia C; Ariano R; Berto P; Ciprandi G; Leo G; Boccardo R; Scurati S; Frati F
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):27-30. PubMed ID: 19944007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
    Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
    Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of sublingual immunotherapy: an analysis of literature.
    Ciprandi G; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Incorvaia C; Danneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():21-6. PubMed ID: 18924463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):244. PubMed ID: 17124783
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergen-specific sublingual immunotherapy: less mystic, more scientific.
    Bieber T
    Allergy; 2006 Feb; 61(2):149-50. PubMed ID: 16409189
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
    Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
    [No Abstract]   [Full Text] [Related]  

  • 15. Sublingual immunotherapy.
    Heinzerling L; Worm M; Bergmann KC; Zuberbier T
    J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
    Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
    [No Abstract]   [Full Text] [Related]  

  • 17. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy for food allergy.
    Enrique E
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():329-36; discussion 337. PubMed ID: 20799477
    [No Abstract]   [Full Text] [Related]  

  • 19. Sublingual immunotherapy: adherence based on timing and monitoring control visits.
    Vita D; Caminiti L; Ruggeri P; Pajno GB
    Allergy; 2010 May; 65(5):668-9. PubMed ID: 19845569
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.